Management of externally manufactured cell therapy products: the Mayo Clinic approach-Reference-Cited by-同舟云学术

Management of externally manufactured cell therapy products: the Mayo Clinic approach

Published:2022-01 Issue:1 Volume:24 Page:19-26
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Wiltshire Timothy D.,Deeds Michael C.,Radel Darcie J.,Bornschlegl Alexander M.,Schmidt Clint S.,Thebiay Julia M.,Pelleymounter Linda L.,Jacob Eapen K.,Stubbs James R.,Gastineau Dennis A.,Dietz Allan B.

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy

Reference23 articles.

1. The therapy of the Cook County Hospital;Fantus;Journal of the American Medical Association,1938

2. A Brief History of the Early Years of Blood Transfusion at the Mayo Clinic: The First Blood Bank in the United States (1935);Moore;Transfusion Medicine Reviews,2005

3. The homotransplantation of functional erythropoietic elements in the rat following total-body irradiation;Odell;Annals of the New York Academy of Sciences,1957

4. Effect of transplantation of bone marrow into irradiated animals;Rekers;Archives of Surgery,1950

5. Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication;Barnes;Br Med J,1956

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A hub-and-spoke model to deliver effective access to chimeric antigen receptor T-cell therapy in a public health network: the Catalan Blood and Tissue Bank experience;Cytotherapy;2023-01

2. Comparative evaluation of propolis nanostructured lipid carriers and its crude extract for antioxidants, antimicrobial activity, and skin regeneration potential;BMC Complementary Medicine and Therapies;2022-10-03